Application 062334

Type
ANDA
Sponsor
APOTHECON

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEFADROXILCEFADROXIL/CEFADROXIL HEMIHYDRATEFOR SUSPENSION;ORALEQ 125MG BASE/5MLNoNo
002CEFADROXILCEFADROXIL/CEFADROXIL HEMIHYDRATEFOR SUSPENSION;ORALEQ 250MG BASE/5MLNoNo
003CEFADROXILCEFADROXIL/CEFADROXIL HEMIHYDRATEFOR SUSPENSION;ORALEQ 500MG BASE/5MLNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062334-001CEFADROXILCEFADROXIL/CEFADROXIL HEMIHYDRATEEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982
A062334-002CEFADROXILCEFADROXIL/CEFADROXIL HEMIHYDRATEEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982
A062334-003CEFADROXILCEFADROXIL/CEFADROXIL HEMIHYDRATEEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2024-10-29 15:01 UTC2024-10A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982d06236e962d9…
2024-10-29 15:01 UTC2024-10A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 198279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 198279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19821e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 19821e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19828072bd15b7f6…
2024-05-31 18:47 UTC2024-05A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 19828072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19824b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 19824b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 198274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 198274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982782e0a99824c…
2021-12-28 21:50 UTC2021-12A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 1982782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 198287673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 198287673890dc5c…
2021-03-12 10:30 UTC2021-03A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A062334-003CEFADROXILEQ 500MG BASE/5MLFOR SUSPENSION / ORALApproved before 19825aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062334-001CEFADROXILEQ 125MG BASE/5MLFOR SUSPENSION / ORALApproved before 19828869cabd3fbd…
2020-12-22 03:56 UTC2020-12A062334-002CEFADROXILEQ 250MG BASE/5MLFOR SUSPENSION / ORALApproved before 19828869cabd3fbd…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 36 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CefadroxilCEFADROXILPD-Rx Pharmaceuticals, Inc.f5bbbf87-f059-4bbd-aea9-27d31462654f2026-11-09Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILPD-Rx Pharmaceuticals, Inc.ab9cf28c-7c16-4bfa-879d-c360b4d1d5a62026-11-09Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILProficient Rx LP57eebea5-28b6-44a3-888b-76950f6038f42026-06-01Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILRedpharm Drug4fb524c1-f985-2a8f-e063-6394a90aab7f2026-04-18Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILREMEDYREPACK INC.eb365f05-1c8f-4495-b443-abb0580b39fb2026-04-13Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILPreferred Pharmaceuticals, Inc.485bc35b-637a-426b-aaa2-023c664914ae2026-03-24Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILPreferred Pharmaceuticals Inc.41bc5f5a-5e1d-4cb6-a795-9f1756a8f0742026-03-24Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILRedPharm Drug, Inc.97193a92-12ff-cfab-e053-2a95a90a9f142026-01-23Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILRedpharm Drug1c50c0db-ca03-6217-e063-6294a90a89fa2025-12-25Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILRedpharm Drug45ac01b1-b5b7-6fc1-e063-6394a90a271a2025-12-11Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILNuCare Pharmaceuticals,Inc.7e931c7e-5ab6-c39c-e053-2a91aa0a59d92025-11-19Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILLupin Pharmaceuticals, Inc.5fe066ce-2f97-49d7-81bd-a672be1ebecd2025-10-10Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILLupin Pharmaceuticals, Inc.27009a05-4d2b-4618-be76-39f348240eda2025-10-08Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILBryant Ranch Prepackcaee9515-9a10-4020-af47-e9833aa69ef82025-06-20Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILDirect_Rxf6ddd84a-4a44-7035-e053-6294a90a66062025-01-22Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CEFADROXILCEFADROXILDIRECT RXa7e74b63-9d5c-7baa-e053-2a95a90a98b22025-01-17Warnings, Adverse reactionsName fallback
brand name: CEFADROXIL
CefadroxilCEFADROXILTeva Pharmaceuticals USA, Inc.bda86975-8c2f-4c4e-9a4c-a1a959f9336a2024-12-30Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILTeva Pharmaceuticals USA, Inc.4674a05c-fdef-4737-a4b8-e3229bdada9d2024-12-30Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILAdvanced Rx of Tennessee, LLC205cb17b-6fbf-e147-e063-6294a90a608e2024-08-23Warnings, Adverse reactionsName fallback
brand name: Cefadroxil
CefadroxilCEFADROXILDirect_Rx02566385-46f3-255a-e063-6294a90a1d1c2024-06-26Warnings, Adverse reactionsName fallback
brand name: Cefadroxil

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.